Overview

BIBR 277 Capsules in Hypertensive Patients With Nephropathy

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The antihypertensive effect, safety and usefulness of treatment with BIBR 277 capsules were evaluated in hypertensive patients with nephropathy
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Telmisartan